TOOLS/TECHNIQUES
tags: weeklylinks
o The survey captures the purchasing,
budget, application, and technology trends of research antibody use.
Additionally, the survey determines customer ratings of suppliers, supplier
usage, unmet needs, and challenges.
tags: weeklylinks
o The Bill & Melinda Gates
Foundation is investing $52 million in CureVac, a German company involved in
making vaccines. It is the largest ever investment by the foundation in a company,
reflecting a new strategy of not just giving grants but supporting and having a
stake in businesses.
The
investment, part of a round of $76 million round for CureVac, will allow
the construction of a manufacturing plant
tags: weeklylinks
o Arrowhead Research CEO Christopher
Anzalone thinks he just got a massive bargain. For just $35 million, his company grabbed Novartis’ last
remaining RNA interference assets: a group of patents and preclinical drug
candidates that give Arrowhead more technological tools to play with
tags: weeklylinks
tags: weeklylinks
o Thermo Fisher will utilize the
technology to develop and market new CRISPR reagent kits, bringing new
tools to researchers working in the rapidly growing field. The kits will
augment Thermo Fisher’s strong portfolio in the complementary transcription
activator-like effector nucleases (TALEN) technique .
No comments:
Post a Comment